Ascendis Pharma A (ASND) Profit After Tax (2014 - 2026)
Ascendis Pharma A (ASND) posted Profit After Tax of $736.8 million for Q1 2026, up 1985.95% sequentially from -$39.1 million in Q4 2025, and up 640.23% YoY from $99.5 million in Q1 2025.
Ascendis Pharma A (ASND) Profit After Tax (2014 - 2026) Analysis & Trends
Ascendis Pharma A has reported Profit After Tax for 13 years, with the latest figure at $736.8 million in Q1 2026.
- Quarterly Profit After Tax rose 640.23% year-over-year to $736.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $670.4 million (up 498.34% YoY) and the FY2025 annual result came in at -$265.4 million, up 34.3% from the prior year.
- Profit After Tax advanced to $736.8 million in Q1 2026 per ASND's latest filing, from -$39.1 million in the prior quarter.
- Over five years, Profit After Tax peaked at $736.8 million in Q1 2026 and troughed at -$211.6 million in Q4 2022.
- A 5-year average of -$14.6 million and a median of -$86.8 million in 2022 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2026: Profit After Tax slumped 2888983.71% in 2022, then jumped 640.23% in 2026.
- Over 5 years, Profit After Tax stood at -$211.6 million in 2022, then jumped by 55.83% to -$93.5 million in 2023, then surged by 56.02% to -$41.1 million in 2024, then climbed by 4.96% to -$39.1 million in 2025, then surged by 1985.95% to $736.8 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered $736.8 million, -$39.1 million, and -$71.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | 736.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 736.80 Mn |
| Dec 31, 2025 | -39.07 Mn |
| Sep 30, 2025 | -71.30 Mn |
| Jun 30, 2025 | 43.98 Mn |
| Mar 31, 2025 | 99.54 Mn |
| Dec 31, 2024 | -41.11 Mn |
| Sep 30, 2024 | -108.94 Mn |
| Jun 30, 2024 | -117.79 Mn |
| Mar 31, 2024 | 142.35 Mn |
| Dec 31, 2023 | -93.48 Mn |
| Sep 30, 2023 | -176.59 Mn |
| Jun 30, 2023 | -132.23 Mn |
| Mar 31, 2023 | 119.05 Mn |
| Dec 31, 2022 | -211.62 Mn |
| Sep 30, 2022 | -170.35 Mn |
| Jun 30, 2022 | -86.77 Mn |
| Mar 31, 2022 | -140.85 Mn |
| Dec 31, 2021 | -439.09 Mn |
| Sep 30, 2021 | -5,896.44 |
| Jun 30, 2021 | 81,890.46 |